{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:40:46Z","timestamp":1766266846589},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T00:00:00Z","timestamp":1170892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2007,2,28]]},"DOI":"10.1007\/s00210-007-0134-1","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T11:17:24Z","timestamp":1170847044000},"page":"39-49","source":"Crossref","is-referenced-by-count":31,"title":["Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017"],"prefix":"10.1007","volume":"375","author":[{"given":"T.","family":"Na","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Z.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. Y.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,8]]},"reference":[{"key":"134_CR1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0735-1097(01)01185-8","volume":"37","author":"PB Adamson","year":"2001","unstructured":"Adamson PB, Vanoli E (2001) Early autonomic and repolarization abnormalities contribute to lethal arrhythmias in chronic ischemic heart failure: characteristics of a novel heart failure model in dogs with postmyocardial infarction left ventricular dysfunction. J Am Coll Cardiol 37:1741\u20131748","journal-title":"J Am Coll Cardiol"},{"key":"134_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.physiol.62.1.413","volume":"62","author":"RS Ahima","year":"2000","unstructured":"Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413\u2013437","journal-title":"Annu Rev Physiol"},{"key":"134_CR3","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1074\/jbc.M308351200","volume":"279","author":"Q Cao","year":"2004","unstructured":"Cao Q, Mak KM, Ren C, Lieber CS (2004) Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK\/STAT and JAK-mediated H2O2-dependant MAPK pathways. J Biol Chem 279:4292\u20134304","journal-title":"J Biol Chem"},{"key":"134_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1527-3466.2006.00101.x","volume":"24","author":"DZ Dai","year":"2006","unstructured":"Dai DZ (2006) CPU86017: a novel class III antiarrhythmic agent with multiple actions at ion channels. Cardiovasc Drug Rev 24:101\u2013115","journal-title":"Cardiovasc Drug Rev"},{"key":"134_CR5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1745-7254.2005.00134.x","volume":"26","author":"DZ Dai","year":"2005","unstructured":"Dai DZ, Yu F (2005) Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias. Acta Pharmacol Sin 26:918\u2013925","journal-title":"Acta Pharmacol Sin"},{"key":"134_CR6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/hc0802.105564","volume":"105","author":"F Monte del","year":"2002","unstructured":"del Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ (2002) Targeting phospholamban by gene transfer in human heart failure. Circulation 105:904\u2013907","journal-title":"Circulation"},{"key":"134_CR7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bjp.0706193","volume":"145","author":"F Dong","year":"2005","unstructured":"Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J (2005) Endothelin-1 oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 145:323\u2013333","journal-title":"Br J Pharmacol"},{"key":"134_CR8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.HYP.0000198555.51645.f1","volume":"47","author":"F Dong","year":"2006","unstructured":"Dong F, Zhang X, Ren J (2006a) Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension 47:222\u2013229","journal-title":"Hypertension"},{"key":"134_CR9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1677\/joe.1.06241","volume":"188","author":"F Dong","year":"2006","unstructured":"Dong F, Zhang X, Yang X, Esberg LB, Yang H, Zhang Z, Culver B, Ren J (2006b) Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob\/ob obese mice. J Endocrinol 188:25\u201336","journal-title":"J Endocrinol"},{"key":"134_CR10","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1097\/01.fjc.0000166214.42791.f2","volume":"44","author":"B Francis","year":"2004","unstructured":"Francis B, Winaver J, Karram T, Hoffman A, Abassi Z (2004) Renal and systemic effects of chronic blockade of ETA or ETB receptors in normal rats and animals with experimental heart failure. J Cardiovasc Pharmacol 44:S54\u2013S58","journal-title":"J Cardiovasc Pharmacol"},{"key":"134_CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10863-005-9474-z","volume":"37","author":"D Gianni","year":"2005","unstructured":"Gianni D, Chan J, Gwathmey JK, del Monte F, Hajjar RJ (2005) SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr 37:375\u2013380","journal-title":"J Bioenerg Biomembr"},{"issue":"Suppl 4","key":"134_CR12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00392-006-2006-y","volume":"95","author":"S Gotze","year":"2006","unstructured":"Gotze S, Butter C, Fleck E (2006) Cardiac resynchronization therapy for heart failure-From experimental pacing to evidence-based therapy. Clin Res Cardiol 95 Suppl 4:18\u201335","journal-title":"Clin Res Cardiol"},{"key":"134_CR13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1745-7254.2006.00373.x","volume":"27","author":"HB He","year":"2006","unstructured":"He HB, Dai DZ, Dai Y (2006) CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats. Acta Pharmacol Sin 27:1213\u20131221","journal-title":"Acta Pharmacol Sin"},{"key":"134_CR14","doi-asserted-by":"crossref","first-page":"H1194","DOI":"10.1152\/ajpheart.00563.2003","volume":"287","author":"AF Leite-Moreira","year":"2004","unstructured":"Leite-Moreira AF, Bras-Silva C (2004) Inotropic effects of ETB receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins. Am J Physiol Heart Circ Physiol 287:H1194\u2013H1199","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"134_CR15","first-page":"281","volume":"9","author":"Q Liu","year":"2004","unstructured":"Liu Q, Dai DZ (2004) Influence of a new endothelin receptor antagonist CPU20213 on expression of mRNA of MMPs and TIMPs in hypertrophic myocardium induced by L-thyroxin in rats. Chin J Basal & Clin Pharmacol Ther 9:281\u2013284","journal-title":"Chin J Basal & Clin Pharmacol Ther"},{"key":"134_CR16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm1151","volume":"4","author":"DH MacLennan","year":"2003","unstructured":"MacLennan DH, Kranias EG (2003) Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4:566\u2013577","journal-title":"Nat Rev Mol Cell Biol"},{"key":"134_CR17","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/01.HYP.0000218452.18010.fb","volume":"47","author":"H Morawietz","year":"2006","unstructured":"Morawietz H, Bornstein SR (2006) Leptin, endothelin, NADPH oxidase, and heart failure. Hypertension 47:e20; author reply e20\u2013e21","journal-title":"Hypertension"},{"key":"134_CR18","doi-asserted-by":"crossref","unstructured":"Na T, Huang ZJ, Dai DZ, Zhang Y, Dai Y (2006) Abrupt changes in expression of FKBP12.6 & SERCA2a contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017. Acta Pharmacol Sin (in press)","DOI":"10.1111\/j.1745-7254.2007.00580.x"},{"key":"134_CR19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/hc3601.095575","volume":"104","author":"N Nagaya","year":"2001","unstructured":"Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, Hosoda H, Hirota Y, Ishida H, Mori H, Kangawa K (2001) Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104:1430\u20131435","journal-title":"Circulation"},{"key":"134_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nm0504-467","volume":"10","author":"EN Olson","year":"2004","unstructured":"Olson EN (2004) A decade of discoveries in cardiac biology. Nat Med 10:467\u2013474","journal-title":"Nat Med"},{"key":"134_CR21","doi-asserted-by":"crossref","first-page":"H2877","DOI":"10.1152\/ajpheart.00499.2004","volume":"287","author":"DM Purdham","year":"2004","unstructured":"Purdham DM, Zou M-X, Rajapurohitam V, Karmazyn M (2004) Rat heart is a site of leptin production and action. Am J Physiol Heart Circ Physiol 287:H2877\u2013H2884","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"134_CR22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.fjc.0000211765.52012.aa","volume":"47","author":"MY Qi","year":"2006","unstructured":"Qi MY, Xia HJ, Dai DZ, Dai Y (2006) A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats. J Cardiovasc Pharmacol 47:729\u2013735","journal-title":"J Cardiovasc Pharmacol"},{"key":"134_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1810001","volume":"181","author":"J Ren","year":"2004","unstructured":"Ren J (2004) Leptin and hyperleptinemia-from friend to foe for cardiovascular function. J Endocrinol 181:1\u201310","journal-title":"J Endocrinol"},{"key":"134_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2005.05.019","volume":"362","author":"PC Schulze","year":"2005","unstructured":"Schulze PC, Kratzsch J (2005) Leptin as a new diagnostic tool in chronic heart failure. Clin Chim Acta 362:1\u201311","journal-title":"Clin Chim Acta"},{"key":"134_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1388-9842(02)00177-0","volume":"5","author":"PC Schulze","year":"2003","unstructured":"Schulze PC, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, Erbs S, Moebius-Winkler S, Schuler G (2003) Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 5:33\u201340","journal-title":"Eur J Heart Fail"},{"key":"134_CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00129784-200202040-00001","volume":"2","author":"K Seidl","year":"2002","unstructured":"Seidl K, Rameken M, Vater M, Senges J (2002) Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience. Am J Cardiovasc Drugs 2:219\u2013226","journal-title":"Am J Cardiovasc Drugs"},{"key":"134_CR27","first-page":"611","volume":"136","author":"C Sticherling","year":"2006","unstructured":"Sticherling C, Schaer B, Coenen M, Kuhne M, Ammann P, Osswald S (2006) Cardiac resynchronization therapy in chronic heart failure. Swiss Med Wkly 136:611\u2013617","journal-title":"Swiss Med Wkly"},{"key":"134_CR28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-005-0519-6","volume":"100","author":"MB Thomsen","year":"2005","unstructured":"Thomsen MB, Truin M, van Opstal JM, Beekman JD, Volders PG, Stengl M, Vos MA (2005) Sudden cardiac death in dogs with remodeled hearts is associated with larger beat-to-beat variability of repolarization. Basic Res Cardiol 100:279\u2013287","journal-title":"Basic Res Cardiol"},{"key":"134_CR29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/hh0202.103613","volume":"90","author":"T Tsuruda","year":"2002","unstructured":"Tsuruda T, Jougasaki M, Boerrigter G, Huntley BK, Chen HH, D\u2019Assoro AB, Lee SC, Larsen AM, Cataliotti A, Burnett JC Jr (2002) Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130\/leukemia inhibitory factor receptor and the endothelin type A receptor. Circ Res 90:128\u2013134","journal-title":"Circ Res"},{"key":"134_CR30","first-page":"130","volume":"31","author":"HL Wang","year":"2000","unstructured":"Wang HL, Li SB, Dai DZ (2000) Change on L-type calcium current in single guinea pig hypertrophic ventricular myocytes induced by levothyroxine. J China Pharmaceut Univ 31:130\u2013134","journal-title":"J China Pharmaceut Univ"},{"key":"134_CR31","first-page":"738","volume":"25","author":"HL Wang","year":"2004","unstructured":"Wang HL, Dai DZ, Gao E, Zhang YP, Lu F (2004a) Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats. Acta Pharmacol Sin 25:738\u2013743","journal-title":"Acta Pharmacol Sin"},{"key":"134_CR32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ddr.10383","volume":"63","author":"YQ Wang","year":"2004","unstructured":"Wang YQ, Shi YP, Dai DZ (2004b) Therapeutic effects of CPU 86017 on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats. Drug Dev Res 63:22\u201332","journal-title":"Drug Dev Res"},{"key":"134_CR33","doi-asserted-by":"crossref","unstructured":"Wannamethee SG, Tchernova J, Whincup P, Lowe GD, Kelly A, Rumley A, Wallace AM, Sattar N (2006) Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. (Epub ahead of print, PMID: 16712853)","DOI":"10.1016\/j.atherosclerosis.2006.04.012"},{"key":"134_CR34","doi-asserted-by":"crossref","first-page":"28471","DOI":"10.1074\/jbc.M103478200","volume":"276","author":"Y Xiong","year":"2001","unstructured":"Xiong Y, Tanaka H, Richardson JA, Williams SC, Slaughter CA, Nakamura M, Chen JL, Yanagisawa M (2001) Endothelin-1 stimulates leptin production in adipocytes. J Biol Chem 276:28471\u201328477","journal-title":"J Biol Chem"},{"key":"134_CR35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.CIR.0000140766.52771.6D","volume":"110","author":"FP Xu","year":"2004","unstructured":"Xu FP, Chen MS, Wang YZ, Yi Q, Lin SB, Chen AF, Luo JD (2004) Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 110:1269\u20131275","journal-title":"Circulation"},{"key":"134_CR36","first-page":"451","volume":"31","author":"GQ Zhang","year":"2000","unstructured":"Zhang GQ, Ma YP, Hao XM, Zhou PA, Wu CH, Dai DZ (2000) Rapidly activating delayed rectifier K+ current and inward rectifier K+ current in cardiomyocytes from hypertrophied guinea pig hearts induced by thyroxine. J China Pharmaceut Univ 31:451\u2013454","journal-title":"J China Pharmaceut Univ"},{"key":"134_CR37","first-page":"174","volume":"17","author":"GQ Zhang","year":"2001","unstructured":"Zhang GQ, Hao XM, Ma YP, Zhou PA, Wu CH, Dai DZ (2001) Characteristics of the delayed rectifier K+ current in guinea pig hypertrophied ventricular myocytes induced by thyroxin. China Pharmacol Bull 17:174\u2013177","journal-title":"China Pharmacol Bull"},{"key":"134_CR38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.fjc.0000184470.58047.79","volume":"46","author":"TT Zhang","year":"2005","unstructured":"Zhang TT, Cui B, Dai DZ, Tang XY (2005) Pharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats: mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathway. J Cardiovasc Pharmacol 46:727\u2013734","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0134-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-007-0134-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-007-0134-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T17:08:10Z","timestamp":1683738490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-007-0134-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,8]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2,28]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1007\/s00210-007-0134-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,8]]}}}